The Domestic and International Impacts of the 2009-H1N1 Influenza A Pandemic: Global Challenges, Global Solutions: Workshop Summary (2010)
Chapter: Appendix B Agenda
Appendix B
Agenda
The Domestic and International Impacts of the 2009-H1N1 Influenza A Pandemic: Global Challenges, Global Solutions
September 15-16, 2009
Keck Building, Room 100
500 Fifth Street, NW
Washington, DC
DAY 1: SEPTEMBER 15, 2009
|
8:00-8:15 |
Continental Breakfast |
|
8:15-8:30 |
Welcoming Remarks: David A. Relman, M.D., Chair, and James M. Hughes, M.D., Vice-Chair, Forum on Microbial Threats |
|
8:30-9:15 |
Keynote Address The 2009 Influenza Pandemic: Lessons for Going Forward |
|
|
Keiji Fukuda, M.D., M.P.H. World Health Organization |
|
9:15-9:45 |
Keynote Address Swine Flu: 33 Years Onward (via DVD and teleconference) |
|
|
David Sencer, M.D., M.P.H. |
|
9:45-10:15 |
Discussion |
|
10:15-10:30 |
Break |
Session I
Evolution, Genomics, and Pathogenicity of the New H1N1 Influenza A Virus
Moderator: David A. Relman, M.D.
|
10:30-10:55 |
Rates and Dates: Origins and Emergence of the 2009 Influenza A H1N1 Pandemic Virus |
|
|
Michael Worobey, D.Phil. University of Arizona |
|
10:55-11:20 |
The Ongoing Evolution of the H1N1 Pandemic |
|
|
Eddie Holmes, Ph.D. Pennsylvania State University |
|
11:20-11:45 |
In Vitro and In Vivo Characterization of New Swine-Origin H1N1 Influenza Viruses |
|
|
Yoshihiro Kawaoka, D.V.M., Ph.D. University of Wisconsin |
|
11:45-12:10 |
Pathology and Pathogenesis of Fatal Novel Influenza A H1N1 2009 |
|
|
Sherif Zaki, M.D., Ph.D. Centers for Disease Control and Prevention |
|
12:10-12:35 |
Detection and Characterization of and Response to the Emergence of 2009 H1N1 Viruses |
|
|
Nancy Cox, Ph.D. Centers for Disease Control and Prevention |
|
12:35-1:00 |
Discussion of Session I |
|
1:00-1:45 |
Lunch |
Session II
Potential Lessons Learned from the Southern Hemisphere Experiences
Moderator: Eduardo Gotuzzo, M.D.
|
1:45-2:15 |
Ground Zero: The Origins of a Pandemic? |
|
|
Guillermo Ruiz-Palacios, M.D. National Institute of Medical Sciences and Nutrition, Mexico |
|
2:15-2:45 |
Clinical and Epidemiological Experience in South America |
|
|
Eduardo Gotuzzo, M.D. Universidad Peruana Cayetano Heredia, Peru |
|
2:45-3:15 |
2009 Influenza A H1N1 Pandemic in Argentina |
|
|
Osvaldo Uez, M.D. Instituto Nacional de Epidemiologia, Argentina |
|
3:15-3:30 |
Break |
|
3:30-4:00 |
Southern Hemisphere, Northern Hemisphere: A Global Influenza World |
|
|
Ken Shortridge, Ph.D. The University of Hong Kong |
|
4:00-4:30 |
Epidemiology of Seasonal and Pandemic Influenza A (H1N1) in South Africa, 2009 |
|
|
Barry Schoub, Ph.D., D.Sc. National Institute of Communicable Diseases, South Africa |
|
4:30-5:15 |
Open Discussion of Session II |
|
5:15-6:00 |
Open discussion of Day 1 and adjournment |
|
6:30-9:00 |
Working dinner for Forum members, speakers, and staff |
DAY 2: SEPTEMBER 16, 2009
|
8:30-9:00 |
Continental Breakfast |
|
9:00-9:15 |
Summary of Day 1: James M. Hughes, M.D. |
Session III
Surveillance, Monitoring, Epidemiology, and Spread of Pandemic Disease
Moderator: Lonnie King, D.V.M.
|
9:15-9:45 |
Rumors of Pandemic: Monitoring Emerging Disease Outbreaks on the Internet |
|
|
Larry Madoff, M.D. University of Massachusetts |
|
9:45-10:15 |
Modeling and Epidemiology of H1N1 Pandemic |
|
|
Marc Lipsitch, D.Phil. Harvard University |
|
10:15-10:30 |
Break |
|
10:30-11:00 |
Deciphering the Origins of Pandemics and a “Smart” Surveillance Strategy to Prevent Them |
|
|
Peter Daszak, Ph.D. Wildlife Trust |
|
11:00-11:30 |
2009 Influenza A H1N1: Challenges for the Healthcare Setting |
|
|
Michael Bell, M.D. Centers for Disease Control and Prevention |
|
11:30-12:00 |
Discussion of Session III |
|
12:00-1:00 |
Luncheon remarks |
|
|
Jesse Goodman, M.D., M.P.H. Food and Drug Administration |
Session IV
Contemporary Aspects of the Public Health Responses
Moderator: Michael Osterholm, Ph.D.
|
1:00-1:40 |
International Law and Equitable Access to Vaccines and Antiviral Medications |
|
|
David Fidler, J.D. Indiana University |
|
1:40-2:05 |
Ethical Issues in Responding to the H1N1 Pandemic |
|
|
Bernard Lo, M.D. University of California San Francisco |
|
2:05-2:30 |
Considerations in H1N1 Vaccination |
|
|
John Treanor, M.D. University of Rochester |
|
2:30-2:55 |
Influenza Antivirals for Pandemic H1N1: Overview |
|
|
Fred Hayden, M.D. University of Virginia |
|
2:55-3:10 |
Break |
|
3:10-3:35 |
Nonpharmaceutical Interventions |
|
|
Martin Cetron, M.D. Center for Disease Control and Prevention |
|
3:35-4:00 |
Pandemic 2009 Influenza A (H1N1)—A Local Perspective |
|
|
Jeffery Duchin, M.D. Seattle-King County Department of Public Health |
|
4:00-4:25 |
The H1N1 Experience in New York City—Lessons Learned and Approaches for the Fall |
|
|
Annie Fine, M.D. NYC Department of Health |
|
4:25-5:00 |
Open Discussion |
|
5:00-5:15 |
Wrap-Up and Adjournment |
|
|
James M. Hughes, M.D. |
